euthanimal 40% 400 mg/ml inj. sol. i.v./i.card. vial
alfasan nederland b.v. - pentobarbital sodium 400 mg/ml - eq. pentobarbital 364,6 mg/ml - solution for injection - 400 mg/ml - pentobarbital sodium 400 mg/ml - pentobarbital - dog; cat; cattle; horse; goat; sheep; pig
euthasol vet 400 mg/ml inj. sol. i.v./i.card./i.perit. vial
dechra regulatory b.v. - pentobarbital sodium 400 mg/ml - solution for injection - 400 mg/ml - pentobarbital sodium 400 mg/ml - pentobarbital - cattle; dog; goat; horse; cat; rabbit; sheep; other species or species not known
euthasol vet. 400 mg/ml, solution for injection
le vet bv - pentobarbital sodium - solution for injection - 400 milligram(s)/millilitre - pentobarbital - cats, cattle, dogs, goats, horses, mink, rabbits, rodents, sheep - neurological preparations
euthasol vet. 400 mg/ml, solution for injection
le vet bv - pentobarbital (as sodium salt) (equivalent to 400 mg pentobarbital sodium ph. eur.) - solution for injection - 400 mg/ml - pentobarbital - bovine, canine, caprine, equine - food, feline, mink, ovine, rabbits, rodent - neurological preparations
pentobarbital sodium injection, solution
sagent pharmaceuticals - pentobarbital sodium (unii: njj0475n0s) (pentobarbital - unii:i4744080ir) - pentobarbital sodium 50 mg in 1 ml - - sedatives. - hypnotics, for the short-term treatment of insomnia, since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks. (see "clinical pharmacology" section.) - preanesthetics. - anticonvulsant, in anesthetic doses, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics. barbiturates are contraindicated in patients with known barbiturate sensitivity. barbiturates are also contraindicated in patients with a history of manifest or latent porphyria. pentobarbital sodium injection is subject to control by the federal controlled substances act under dea schedule ii. barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 milligrams (mg) of pentobarbital or secobar
euthanimal 400 mg/ml, solution for injection.
alfasan nederland b.v - sodium pentobarbital - solution for injection - 400 mg/ml - pentobarbital - bovine, canine, equine non food, feline, ovine, porcine - neurological preparations
euthanimal 400 mg/ml, solution for injection
alfasan nederland b.v - sodium pentobarbital - solution for injection - 400 milligram(s)/millilitre - pentobarbital - cats, cattle, dogs, non food-producing horses, pigs, sheep - neurological preparations
euthoxin 500 mg/ml solution for injection
chanelle pharmaceuticals manufacturing limited - pentobarbital (equivalent to 500 mg pentobarbital sodium ph. eur.) - solution for injection - 500 mg/ml - pentobarbital - avian, bovine, canine, equine non food, feline, fowl - chicken, guinea pigs, hamsters, mink, non food animals, porcine, rabbits, - neurological preparations
pentobarbital sodium injection, solution
hikma pharmaceuticals usa inc. (dba leucadia pharmaceuticals) - pentobarbital sodium (unii: njj0475n0s) (pentobarbital - unii:i4744080ir) - - sedatives. - hypnotics, for the short-term treatment of insomnia, since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks (see " clinical pharmacology " section). - preanesthetics. - anticonvulsant, in anesthetic doses, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics. barbiturates are contraindicated in patients with known barbiturate sensitivity. barbiturates are also contraindicated in patients with a history of manifest or latent porphyria. pentobarbital sodium injection is subject to control by the federal controlled substances act under dea schedule ii. barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 milligrams (mg) of pentob
pentobarbital sodium injection
renaissance ssa, llc - pentobarbital sodium (unii: njj0475n0s) (pentobarbital - unii:i4744080ir) - p a r e n t e r a l : - sedatives. - hypnotics, for the short-term treatment of insomnia, since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks (see “clinical pharmacology” section.) - preanesthetics. - anticonvulsant, in anesthetic doses, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics. barbiturates are contraindicated in patients with known barbiturate sensitivity. barbiturates are also contraindicated in patients with a history of manifest or latent porphyria. pentobarbital sodium injection is subject to control by the federal controlled substances act under dea schedule ii. barbiturates may be habit forming. tolerance, psychological dependence, and physical dependence may occur especially following prolonged use of high doses of barbiturates. daily administration in excess of 400 milligrams (mg) of pen